San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Edico Genome Gets $10 Million in Series A Financing

Edico Genome, a San Diego bioinformatics chip maker, announced July 17 that it received $10 million in Series A venture funds.

By Brad Graves July 17, 2014 4:31 a.m.   Share

PaxVax Secures $62 Million in Funding

PaxVax, Inc., a Redwood City-based vaccine company with manufacturing facilities in San Diego, announced that it has secured up to $62 million in additional funding as part of the acquisition of an oral typhoid vaccine, Vivotif, from Crucell Switzerland AG.

Quidel Receives FDA Clearance for Strep Diagnostic

Quidel Corp., a San Diego-based diagnostics company, has received FDA clearance for its molecular diagnostic test, AmpliVue GAS Assay, used for detecting Group A strep.

Cypher Genomics Inc. Teams With Illumina, Also Names President and COO

San Diego-based Cypher Genomics Inc. announced a co-promotion agreement with Illumina Inc. and the selection of Adam Simpson as president and chief operating officer.

Tease photo

DJO Global Reports Q2 Results

DJO Global Inc., the Vista-based maker of orthopedic devices, reporter second quarter net sales of $313.9 million, up 6.5 percent from the like quarter of 2013.

Pfenex Raises $50 Million in IPO

Pfenex Inc., a Sorrento Valley biotech firm specializing in a class of drugs called biosimilars, raised $50 million in its initial public offering July 23, selling 8.33 million shares at $6 per share.

La Jolla Pharmaceutical Prices Stock Offering

La Jolla Pharmaceutical Co., a developer of therapeutics targeting unmet life-threatening diseases, announced a price of $10.50 per share for a planned underwritten stock offering of 4.8 million shares of common stock.

Tease photo

Illumina Reports Q2 Results

Illumina Inc. reported revenue of $448 million for the second quarter ending June 29.

La Jolla Pharmaceutical Announces Proposed Common Stock Offering

La Jolla Pharmaceutical Co., a developer of therapeutics targeting unmet life-threatening diseases, intends to sell shares of common stock in an underwritten offering pursuant to its existing shelf registration statement, the company announced.

Marletta Intends to Step Down as President, CEO of The Scripps Research Institute

The Scripps Research Institute CEO and President Michael Marletta intends to step down, according to the organization’s board of trustees.

Tease photo

Dansky Named CEO at Agena Bioscience

San Diego-based Agena Bioscience, Inc. said that Peter Dansky has joined the company as its chief executive officer and as a member of the board of directors.

Tease photo

Sanchez Named CIO at AMN Healthcare

AMN Healthcare Services Inc. has promoted Jeanette Sanchez to chief information officer, the company announced.

Tease photo

ResMed's Patents Infringed on by Taiwanese Humidifier Maker, ITC Rules

The International Trade Commission finds continued patent infringement despite products being redesigned.

Tease photo

Sorrento Therapeutics Awarded NIH Grant for Development of Small Molecule Protein Inhibitor

The grant supports research based on biotechnology licensed from The Scripps Research Institute.

Tease photo

Arena Pharmaceuticals Forges Marketing and Supply Agreement for Weight-Loss Drug in Israel

Arena Pharmaceuticals will be eligible for milestone payments.

Companies Vie for Temporary Staffing Work at San Diego-Area Navy Hospitals

Task orders under the contract could be worth up to $130.4 million.